Mediseek
en_ENfr_FR

Browse by alphabet

0 1 2 3 4 5 6 7 8 9
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z

Common search terms

- semi-daonil
- intumescent cataract
- colloid adenoma
- bonviva
- giant cell astrocytoma
- pectoral muscles
- sickling
- peptostreptococcus micros
- analgesics
- crescent cell anaemia
- horseshoe kidney
- epstein´s pearls
- warm agglutinins
- myalgia
- tinea cruris
- smooth chorion
- uncal herniation
- social phobia
- dominant gene
- methylcellulose
 
Pages for ara-c
1
 

Newcastle Hospitals - Ara-C + Mylotarg

Patients and Visitors / Help / Contact Us / Jobs ... Your Treatment: Your doctor has prescribed for you a treatment known as Ara-C + Mylotarg. ... 2. Mylotarg is also given as an intravenous infusion via a portable pump into...
http://www.newcastle-hospitals.org.uk/services/haematology_treatment-and-medication_arac-mylotarg.aspx
2
 

Age related change in the frequency of ara C-induced chromosome aberrations in human peripheral blood lymphocytes.

Aging Research Center Home Page / All Previous Aging Related Articles / On-line Medical Dictionary / National Library of Medicine's PubMed directory of MEDLINE citations. Age related change in the frequency of ara C-induced...
http://www.arclab.org/medlineupdates/abstract_3573832.html
3
 

There's a Universal Need in the Treatment of AML...

There's a Universal Need in the Treatment of AML... ... **Both arms wer closed in combinationwith Ara-C. ***All randomized patients entered were evaluated. ... * The type and incidence of various side effects seen with...
http://www.meds.com/leukemia/idamycin/universal.html
4
 

e-Prints Soton - Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C

... Complete cytogenetic response (CCR) was achieved in 60 (imatinib, 87%) vs 10 patients (IFN/Ara-C, 14%) after a median observation time of 24 months. Within the first year after CCR, best median ratio BCR-ABL/ABL was...
http://eprints.soton.ac.uk/24883/
5
 

ISRCTN87866680 - 2nd Nordic Mantle-Cell Lymphoma protocol

Welcome / 13 November 2008 / Trial registration ... Interventions INDUCTION: Three series of maxi-CHOP and Ara-C and two series of rituximab: 1. ... High-dose Ara-C: 2.1. ... The interval between each...
http://www.controlled-trials.com/ISRCTN87866680
6
 

Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) usin

Home / Pharmaceutical Reports ... Whereas clinical trials evaluating monotherapy with IM in AML revealed low response rates, Ara-C and IM showed synergistic effects in vitro. ... METHODS: Low-dose...
http://www.leaddiscovery.co.uk/articles/17285599/
7
 

Chronic Myeloid Leukemia - New Treatments, May 2, 2008

Click here to view next page of this article / New Treatments for Chronic Myeloid Leukemia ... And we did two studies with homoharringtonine alone or with ara-C in now about 170 patients. ... Now your question is; how do we...
http://www.medical-library.org/journals_6a/chronic_myeloid_leukemia.htm
8
 

Childhood Lymphomas

Select A Category / Breast Cancer / Myeloma / Prostate Cancer / Patient Advocacy / Psycho-Social Issues / Skin Cancer ... Treatment for B-cell NHL includes Adriamycin, Ara-C, cyclophosphamide, ifosfamide, methotrexate,...
http://www.cancernews.com/articles/childhoodlymphomas.htm
9
 

Results of a multicenter phase II trial for older ...[Cancer. 2007] - PubMed Result

NCBI ... Whereas clinical trials evaluating monotherapy with IM in AML revealed low response rates, Ara-C and IM showed synergistic effects in vitro. ... METHODS: Low-dose Ara-C (LDAC) combined with IM...
http://www.ncbi.nlm.nih.gov/pubmed/17285599/
10
 

For Investigators

Skip logo, search and navigation. Go to the Content / Search / UoB » Schools and Departments » AML 16 » For Investigators » ... For patients who are considered fit for an intensive approach to treatment, a randomisation will compare the standard...
http://www.aml16.bham.ac.uk/investigators/
 
 
 
1 | 2 | 3 | 4 | 5 | 6 | 7 | >
 
 
Helpful links | About Mediseek | Company | Privacy policy | Contact
Vertical portal made by
www.seekport.biz

© 2007, Seekport Internet Technologies UK Ltd
Seekport Internet Technologies GmbH